# Blue Jet Healthcare (NSE: BLUEJET) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/BLUEJET · Pivot · prices to 22 Oct 2026

Blue Jet Healthcare (NSE: BLUEJET) closed at ₹499.60 on 22 Oct 2026, up 1.50% on the day. With a market capitalisation of ₹9,456 Cr, it ranks 564th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Biotechnology.

At its last close the stock traded at 35× trailing earnings, against a return on equity of 40.7% in FY21. Over the past year the share price has fallen 23.8%. Its 52-week range is ₹325.00 (30 Mar 2026) to ₹688.50 (4 Nov 2025); the last close is 27.4% below the high. In Q1 FY27, the quarter ended 30 Jun 2026, revenue was ₹293 Cr (−17.4% year on year) and net profit ₹78 Cr (−14.2%), on a standalone basis. Promoters held 73.15% of the company as of 9 Jul 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹499.60 |
| Market cap | ₹9,456 Cr |
| P/E (trailing) | 35 |
| ROE | 40.7% (FY21) |
| ROCE | 52.3% (FY21) |
| Debt to equity | 0.11 |
| 52-week high | ₹688.50 (4 Nov 2025) |
| 52-week low | ₹325.00 (30 Mar 2026) |
| 1-year return | −23.8% |

## Quarterly results (₹ crore, standalone)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q1 FY27 | ₹293 Cr | −17.4% | ₹78 Cr | −14.2% | ₹4.51 |
| Q4 FY26 | ₹235 Cr | −31.1% | ₹64 Cr | −41.6% | ₹3.71 |
| Q3 FY26 | ₹192 Cr | −39.6% | ₹40 Cr | −59.4% | ₹2.32 |
| Q2 FY26 | ₹165 Cr | −20.5% | ₹52 Cr | −10.6% | ₹3.01 |
| Q1 FY26 | ₹355 Cr | +117.8% | ₹91 Cr | +141.3% | ₹5.26 |
| Q4 FY25 | ₹340 Cr | +85.1% | ₹110 Cr | +178.8% | ₹6.35 |
| Q3 FY25 | ₹318 Cr | +90.9% | ₹99 Cr | +208.3% | ₹5.71 |
| Q2 FY25 | ₹208 Cr | +14.8% | ₹58 Cr | +21.9% | ₹3.36 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY21 | ₹499 Cr | ₹136 Cr |
| FY20 | ₹538 Cr | ₹145 Cr |

## Shareholding (9 Jul 2026)

- Promoters: 73.15%
- Foreign institutions: 0.62%
- Domestic institutions: 9.12%
- Non-institutions: 17.11%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Metropolis Healthcare](https://app.pivotnow.in/stock/METROPOLIS) | ₹532.25 | ₹11,035 Cr | 57.9 | — |
| [Akums Drugs and Pharmaceuticals](https://app.pivotnow.in/stock/AKUMS) | ₹690.85 | ₹10,874 Cr | 41.5 | — |
| [Park Medi World](https://app.pivotnow.in/stock/PARKHOSPS) | ₹220.45 | ₹9,522 Cr | 32.1 | — |
| [Viyash Scientific](https://app.pivotnow.in/stock/VIYASH) | ₹214.90 | ₹9,388 Cr | 53.6 | — |
| [Strides Pharma Science](https://app.pivotnow.in/stock/STAR) | ₹1,017.30 | ₹9,377 Cr | 16.9 | — |
| [Yatharth Hospital & Trauma Care Services](https://app.pivotnow.in/stock/YATHARTH) | ₹932.10 | ₹8,981 Cr | 51.2 | — |

## Questions and answers

### What is the share price of Blue Jet Healthcare today?

Blue Jet Healthcare (NSE: BLUEJET) last closed at ₹499.60 on 22 Oct 2026. Its 52-week high is ₹688.50 and its 52-week low is ₹325.00.

### What is the market cap of Blue Jet Healthcare?

Blue Jet Healthcare's market capitalisation is ₹9,456 Cr (₹9,456 Cr) at the 22 Oct 2026 close, ranking 564th among the NSE companies Pivot tracks.

### What is the P/E ratio of Blue Jet Healthcare?

Blue Jet Healthcare trades at a trailing P/E of 35. The median P/E of the 6 closest Pharma & Healthcare peers by market cap is 51.2.

### What is the ROE and ROCE of Blue Jet Healthcare?

Return on equity was 40.7% in FY21 and return on capital employed was 52.3% in FY21 (consolidated figures).

### Is Blue Jet Healthcare a debt-free company?

No. Blue Jet Healthcare's debt-to-equity ratio was 0.11 in FY21, with total debt of ₹29 Cr.

### What were Blue Jet Healthcare's latest quarterly results?

For Q1 FY27 (quarter ended 30 Jun 2026), Blue Jet Healthcare reported revenue of ₹293 Cr, −17.4% year on year, and net profit of ₹78 Cr, −14.2% year on year.

### How has Blue Jet Healthcare stock performed over the last year?

Blue Jet Healthcare's share price has fallen 23.8% over the past year, −14.5% over three months and −14.1% over one month, to the 22 Oct 2026 close.

### What is the shareholding pattern of Blue Jet Healthcare?

As of 9 Jul 2026: promoters 73.15%, foreign institutions 0.62%, domestic institutions 9.12%, non-institutions 17.11%.

### Who are Blue Jet Healthcare's competitors?

The listed Pharma & Healthcare companies closest to Blue Jet Healthcare by market cap are Metropolis Healthcare, Akums Drugs and Pharmaceuticals, Park Medi World, Viyash Scientific, Strides Pharma Science and Yatharth Hospital & Trauma Care Services.

### Is Blue Jet Healthcare a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Blue Jet Healthcare's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on BLUEJET against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.